Bafna Pharmaceuticals Ltd. -CIRP – The Hindu BusinessLine

This is in continuation of our earlier intimation dated 05th February 2019 regarding resolution plan which was approved by NCLT, Chennai vide its order dated 01st February 2019 under the Provisions of IBC, 2016.

Pursuant to the Resolution Plan a Monitoring Committee has been formed with the following members / representatives:
Mr. Radhakrishnan Dharmarajan
Mr. Spurgen David – Representative from SBI
Mr. Nagabhusanam – Representative from IDBI
Mr. M. Sridhar and Ms. S. Hemalatha – Representatives from Corporate Debtor

via Bafna Pharmaceuticals Ltd. – Corporate Insolvency Resolution Process (CIRP)-Updates – Corporate Insolvency Resolution Process (CIRP) – The Hindu BusinessLine

Leave a Reply